Ursula McCurry
Direttore Tecnico/Scientifico/R&S presso IMUGENE LIMITED
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Nick Ede | M | - | 11 anni | |
Paul Hopper | M | 68 | 12 anni | |
Leslie Chong | F | - | 9 anni | |
Michael Tonroe | M | 57 | 2 anni | |
Ursula Wiedermann | F | - | - | |
Ciara Kennedy | M | 52 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 anni |
Sharon Yavrom | M | - | 2 anni | |
Bradley Glover | M | 55 | 1 anni | |
Joseph Woodard | M | 58 | 1 anni | |
Anthony Good | M | - | - | |
Lesley Russell | M | 63 | 5 anni | |
Todd Watanabe | M | 56 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 anni |
Jens Eckstein | M | 60 | 5 anni | |
Monil Shah | M | - | 3 anni | |
Jakob Dupont | M | 58 | 2 anni | |
Kimberlee Drapkin | F | 56 | 1 anni | |
John Byon | M | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Angie You | M | 51 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 4 anni |
Patricia Millican | F | 51 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Australia | 15 | 78.95% |
Stati Uniti | 4 | 21.05% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Ursula McCurry
- Contatti personali